Our | Products


Octanate





THERAPEUTIC AREA:
ACTIVE PRINCIPLE: Human coagulation factor VIII
PRESENTATION: 1.000 or 500 UI Powder and solvent for solution for injection
INDICATION:

  • Hemophilia A (deficiency factor VIII)

COUNTRIES WHERE IT IS MARKETED:
Argentina